Literature DB >> 9237865

A one year study of the macular pigment: the effect of 140 days of a lutein supplement.

J T Landrum1, R A Bone, H Joa, M D Kilburn, L L Moore, K E Sprague.   

Abstract

A low density of macular pigment may represent a risk factor for age-related macular degeneration (AMD) by permitting greater blue light damage. This study was carried out to determine the effects on macular pigment optical density of dietary supplementation with lutein, one of the pigment constituents. Two subjects consumed lutein esters, equivalent to 30 mg of free lutein per day, for a period of 140 days. Macular pigment optical density was determined by heterochromatic flicker photometry before, during, and after the supplementation period. Serum lutein concentration was also obtained through the analysis of blood samples by high-performance liquid chromatography. Twenty to 40 days after the subjects commenced taking the lutein supplement, their macular pigment optical density began to increase uniformly at an average rate of 1.13+/-0.12 milliabsorbance units/day. During this same period, the serum concentration of lutein increased roughly tenfold, approaching a steady state plateau. The optical density curve eventually levelled off 40 to 50 days after the subjects discontinued the supplement. During the same 40 to 50 days, the serum concentration returned to baseline. Thereafter, little or no decrease in optical density was observed. The mean increases in the macular pigment optical density were 39% and 21% in the eyes of the two subjects respectively. In conclusion, the modest period of supplementation has been estimated to have produced in the subjects a 30 to 40% reduction in blue light reaching the photoreceptors, Bruch's membrane, and the retinal pigment epithelium, the vulnerable tissues affected by AMD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9237865     DOI: 10.1006/exer.1997.0309

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  79 in total

Review 1.  Macular pigment and age related macular degeneration.

Authors:  S Beatty; M Boulton; D Henson; H H Koh; I J Murray
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

2.  Senescence of foveal and parafoveal cone sensitivities and their relations to macular pigment density.

Authors:  J S Werner; M L Bieber; B E Schefrin
Journal:  J Opt Soc Am A Opt Image Sci Vis       Date:  2000-11       Impact factor: 2.129

3.  Macular pigment density changes in Japanese individuals supplemented with lutein or zeaxanthin: quantification via resonance Raman spectrophotometry and autofluorescence imaging.

Authors:  Masaki Tanito; Akira Obana; Yuko Gohto; Shigetoshi Okazaki; Werner Gellermann; Akihiro Ohira
Journal:  Jpn J Ophthalmol       Date:  2012-06-15       Impact factor: 2.447

4.  Macular pigment optical density measurements: evaluation of a device using heterochromatic flicker photometry.

Authors:  R de Kinkelder; R L P van der Veen; F D Verbaak; D J Faber; T G van Leeuwen; T T J M Berendschot
Journal:  Eye (Lond)       Date:  2010-11-05       Impact factor: 3.775

Review 5.  Lutein and Zeaxanthin Isomers in Eye Health and Disease.

Authors:  Julie Mares
Journal:  Annu Rev Nutr       Date:  2016-07-17       Impact factor: 11.848

6.  Macular pigment density in age-related maculopathy.

Authors:  Cornelia Jahn; Henrike Wüstemeyer; Christian Brinkmann; Sandra Trautmann; Andreas Mössner; Sebastian Wolf
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-10-02       Impact factor: 3.117

7.  Serum levels of macular carotenoids in relation to age-related maculopathy: the Muenster Aging and Retina Study (MARS).

Authors:  Burkhard Dasch; Andrea Fuhs; Joachim Schmidt; Thomas Behrens; Astrid Meister; Juergen Wellmann; Manfred Fobker; Daniel Pauleikhoff; Hans-Werner Hense
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-10-20       Impact factor: 3.117

Review 8.  Intrinsic and Extrinsic Factors Impacting Absorption, Metabolism, and Health Effects of Dietary Carotenoids.

Authors:  Nancy E Moran; Emily S Mohn; Noor Hason; John W Erdman; Elizabeth J Johnson
Journal:  Adv Nutr       Date:  2018-07-01       Impact factor: 8.701

Review 9.  Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress.

Authors:  Edzard Schwedhelm; Renke Maas; Raphael Troost; Rainer H Böger
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

10.  Competitive inhibition of carotenoid transport and tissue concentrations by high dose supplements of lutein, zeaxanthin and beta-carotene.

Authors:  Yingming Wang; D Roger Illingworth; Sonja L Connor; P Barton Duell; William E Connor
Journal:  Eur J Nutr       Date:  2010-01-16       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.